Abstract:Acute haemorrhagic diarrhoea is a common complaint in dogs. In addition to causes like intestinal parasites, dietary indiscretion, intestinal foreign bodies, canine parvovirus infection, or hypoadrenocorticism, acute haemorrhagic diarrhoea syndrome (AHDS) is an important and sometimes life-threatening differential diagnosis. There is some evidence supporting the link between Clostridium perfringens toxins and AHDS. These toxins may be partially responsible for the epithelial cell injury, but the pathogenesis of AHDS is still not fully understood. Recent studies have suggested that severe damage to the intestinal mucosa and associated barrier dysfunction can trigger chronic gastrointestinal illnesses. Besides bloodwork and classical markers for AHDS such as protein loss and intestinal bacterial dysbiosis, we focused mainly on the plasma-proteome to identify systemic pathological alterations during this disease and searched for potential biomarkers to improve the diagnosis. To accomplish the goals, we used liquid chromatography-mass spectrometry. We compared the proteomic profiles of 20 dogs with AHDS to 20 age-, breed-, and sex-matched control dogs. All dogs were examined, and several blood work parameters were determined and compared, including plasma biochemistry and cell counts. We identified and quantified (relative quantification) 207 plasmatic proteins, from which dozens showed significantly altered levels in AHDS. Serpina3, Lipopolysaccharide-binding protein, several Ig-like domain-containing proteins, Glyceraldehyde-3-phosphate dehydrogenase and Serum amyloid A were more abundant in plasma from AHDS affected dogs. In contrast, other proteins such as Paraoxonase, Selenoprotein, Amine oxidases, and Apolipoprotein C-IV were significantly less abundant. Many of the identified and quantified proteins are known to be associated with inflammation. Other proteins like Serpina3 and RPLP1 have a relevant role in oncogenesis. Some proteins and their roles have not yet been described in dogs with diarrhoea. Our study opens new avenues that could contribute to the understanding of the aetiology and pathophysiology of AHDS.

Quantitative demonstration of the existence of two isoforms of canine hepcidin in the serum & urine of dogs

LC-MS/MS method for hepcidin-25 measurement in human and mouse serum: clinical and research implications in iron disorders

A Prospective Observational Study Analyzing the Diagnostic Value of Hepcidin-25 for Anemia in Patients with Inflammatory Bowel Diseases

Expression Pattern of Hepcidin in E.coli Challenged Obese Mice (IRM9P.600)

Advance in Hepcidin

Development of a novel immunoassay for the iron regulatory peptide hepcidin

High Level of Hepcidin Mrna Expression is Associated with High Production of Immune Factors in Tibetan Pigs

Measurement of serum hepcidin-25 by latex agglutination in healthy volunteers and patients with hematologic disorders

Evaluation of a commercial liquid-chromatography high-resolution mass-spectrometry method for the determination of hepcidin-25

Nuclear Factor-Kappa B Mediated Lipopolysaccharide-Induced Mrna Expression Of Hepcidin In Human Peripheral Blood Leukocytes

Hepcidin as a Potential Biomarker for the Diagnosis of Anemia

Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation

Plasma proteome signature of canine acute haemorrhagic diarrhoea syndrome (AHDS)

Factors Influencing Measurement of Serum Iron Concentration in Dogs: Diurnal Variation and Hyperferritinemia

Serum Hepcidin in Haemodialysis Patients: Associations with Iron Status and Microinflammation.

Preliminary Evidence of the Possible Roles of the Ferritinophagy-Iron Uptake Axis in Canine Testicular Cancer

Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice

Hepcidin expression in the liver of mice with implanted tumour reacts to iron deficiency, inflammation and erythropoietin administration

INSL3 Variation in Dogs Following Suppression and Recovery of the HPG Axis

Serum hepcidin evaluation as a promising biomarker in juvenile idiopathic arthritis